Anti-inflammatory effect of fluvastatin on IL-8 production induced by Pseudomonas aeruginosa and Aspergillus fumigatus antigens in cystic fibrosis

Autor: G. Brinchault, Benoit Desrues, Jeanne Galaine, Mélanie Bonizec, Chantal Belleguic, Stéphane Jouneau, Corinne Martin-Chouly, Jean-Pierre Gangneux
Přispěvatelé: Service de pneumologie, Signalisation et Réponses aux Agents Infectieux et Chimiques (SeRAIC), Université de Rennes (UR), Service de Parasitologie-Mycologie [Rennes], Université de Rennes (UR)-Hôpital Pontchaillou-CHU Pontchaillou [Rennes], 'Vaincre la mucoviscidose', le Conseil scientifique de la Faculté de Médecine de l'Université de Rennes 1, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-CHU Pontchaillou [Rennes]
Jazyk: angličtina
Rok vydání: 2011
Předmět:
Male
Pulmonology
Pharmacology
MESH: Terpenes
Aspergillus fumigatus
0302 clinical medicine
MESH: Indoles
0303 health sciences
Clinical Pharmacology
MESH: Case-Control Studies
3. Good health
MESH: Young Adult
[SDV.TOX]Life Sciences [q-bio]/Toxicology
Cytokines
Medicine
Antigens
Fungal

Science
Immunology
Mevalonic Acid
Mevalonic acid
Microbiology
03 medical and health sciences
Inhibitory Concentration 50
Genetics
Humans
Aspergillosis
Pseudomonas Infections
Biology
MESH: Antigens
Fungal

MESH: Adolescent
MESH: Humans
Immunity
MESH: Adult
Molecular Development
MESH: Interleukin-8
030228 respiratory system
chemistry
Pharmacodynamics
Case-Control Studies
MESH: Anti-Inflammatory Agents
Mutation
MESH: Lipopolysaccharides
MESH: Female
Developmental Biology
Lipopolysaccharides
Bacterial Diseases
Chemokine
Indoles
Anatomy and Physiology
Cystic Fibrosis
Anti-Inflammatory Agents
Cystic Fibrosis Transmembrane Conductance Regulator
medicine.disease_cause
Fatty Acids
Monounsaturated

chemistry.chemical_compound
Autosomal Recessive
Immune Physiology
Whole blood
MESH: Inhibitory Concentration 50
MESH: Cystic Fibrosis Transmembrane Conductance Regulator
Multidisciplinary
biology
Fungal Diseases
MESH: Mevalonic Acid
MESH: Fatty Acids
Monounsaturated

Infectious Diseases
Pseudomonas aeruginosa
MESH: Pseudomonas aeruginosa
Female
medicine.symptom
MESH: Aspergillus fumigatus
medicine.drug
Research Article
Adult
Drugs and Devices
MESH: Mutation
Adolescent
MESH: Cystic Fibrosis
Clinical Research Design
Preclinical Models
Inflammation
Young Adult
medicine
Interleukin 8
Fluvastatin
030304 developmental biology
Clinical Genetics
Terpenes
Interleukin-8
Human Genetics
biology.organism_classification
MESH: Male
Immune System
biology.protein
Clinical Immunology
Zdroj: PLoS ONE, Vol 6, Iss 8, p e22655 (2011)
PLoS ONE
PLoS ONE, 2011, 6 (8), pp.e22655. ⟨10.1371/journal.pone.0022655⟩
PLoS ONE, Public Library of Science, 2011, 6 (8), pp.e22655. ⟨10.1371/journal.pone.0022655⟩
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0022655⟩
Popis: International audience; BACKGROUND: Early in life, patients with cystic fibrosis (CF) are infected with microorganisms including bacteria and fungi, particularly Pseudomonas aeruginosa and Aspergillus fumigatus. Since recent research has identified the anti-inflammatory properties of statins (besides their lipid-lowering effects), we investigated the effect of fluvastatin on the production of the potent neutrophil chemoattractant chemokine, IL-8, in whole blood from CF patients, stimulated by Pseudomonas aeruginosa (LPS) and Aspergillus fumigatus (AFA) antigens. RESULTS: Whole blood from adult patients with CF and from healthy volunteers was collected at the Rennes University Hospital (France). Blood was pretreated for 1 h with fluvastatin (0-300 µM) and incubated for 24 h with LPS (10 µg/mL) and/or AFA (diluted 1/200). IL-8 protein levels, quantified by ELISA, were increased in a concentration-dependent manner when cells were stimulated by LPS or AFA. Fluvastatin strongly decreased the levels of IL-8, in a concentration-dependent manner, in whole blood from CF patients. However, its inhibitory effect was decreased or absent in whole blood from healthy subjects. Furthermore, the inhibition induced by fluvastatin in CF whole blood was reversed in the presence of intermediates within the cholesterol biosynthesis pathway, mevalonate, farnesyl pyprophosphate or geranylgeranyl pyrophosphate that activate small GTPases by isoprenylation. CONCLUSIONS: For the first time, the inhibitory effects of fluvastatin on CF systemic inflammation may reveal the important therapeutic potential of statins in pathological conditions associated with the over-production of pro-inflammatory cytokines and chemokines as observed during the manifestation of CF. The anti-inflammatory effect could be related to the modulation of the prenylation of signalling proteins.
Databáze: OpenAIRE